These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15559434)

  • 1. [How I treat ...scalp psoriasis].
    Uhoda I; Flagothier C; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2004 Sep; 59(9):481-4. PubMed ID: 15559434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalp psoriasis.
    Kircik LH; Kumar S
    J Drugs Dermatol; 2010 Aug; 9(8 Suppl ODAC Conf Pt 2):s101-5. PubMed ID: 20715392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
    Freeman K
    Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').
    Høvding G
    Pharmatherapeutica; 1981; 3(1):61-6. PubMed ID: 7033993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.
    Wozel G
    Clin Dermatol; 2008; 26(5):448-59. PubMed ID: 18755363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
    Feldman SR; Levi E; Pathak P; Kakatkar S; Balkrishnan R
    J Med Econ; 2013 Dec; 16(12):1405-13. PubMed ID: 24063352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
    Cassano N; Vena GA
    Acta Derm Venereol; 2007; 87(1):85-6. PubMed ID: 17225026
    [No Abstract]   [Full Text] [Related]  

  • 12. Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
    Downs AM
    Acta Derm Venereol; 2006; 86(1):57-8. PubMed ID: 16585991
    [No Abstract]   [Full Text] [Related]  

  • 13. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
    Scheinfeld NS
    Skinmed; 2011; 9(3):179-80. PubMed ID: 21675498
    [No Abstract]   [Full Text] [Related]  

  • 15. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
    Kragballe K; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():10-21. PubMed ID: 24684739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of topical treatment with desoxymethasone solution 0.25% with salicylic acid 1% and betamethasone valerate solution 0.1% in patients with psoriasis of the scalp.
    Hillström L
    J Int Med Res; 1984; 12(3):170-3. PubMed ID: 6734919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating psoriasis of the scalp with a new corticosteroid lotion.
    Medansky RS; Handler RM
    IMJ Ill Med J; 1974 Jun; 145(6):503-4 passim. PubMed ID: 4152499
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
    Affleck AG; Bottomley JM; Auland M; Jackson P; Ryttov J
    Curr Med Res Opin; 2011 Jan; 27(1):269-84. PubMed ID: 21142836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The calcipotriol-betamethasone dipropionate association].
    Henry F; Flagothier C; Delvoye P; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2005 Nov; 60(11):893-5. PubMed ID: 16402537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.